Product image of Linezolid Accord (Linezolid) supplied by GNH India

Linezolid Accord

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Accord (Linezolid)

Linezolid, the active ingredient in Linezolid Accord, is a oxazolidinone antibiotic presented as an intravenous formulation for injection use. It treats serious Gram‑positive bacterial infections, including those caused by MRSA and VRE, in adult patients requiring hospital care.

GNH India supplies Linezolid Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Accord Healthcare Polska Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid Accord is an oxazolidinone antibiotic used to treat infections caused by susceptible Gram‑positive bacteria.

  • Skin and soft tissue infections: reduces bacterial load and promotes healing of infections caused by susceptible Gram‑positive organisms.
  • Community‑acquired and nosocomial pneumonia: eradicates the causative pathogens and improves respiratory function.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides effective bacterial clearance where other agents may fail.
  • Vancomycin‑resistant Enterococcus (VRE) infections: offers an alternative treatment option for resistant strains.

How It Works

  • Linezolid binds to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex required for bacterial protein synthesis. This inhibition halts bacterial growth, rendering the organism unable to proliferate and allowing the host immune system to clear the infection.

Side Effects

Linezolid may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Peripheral neuropathy: sensory changes that may be irreversible.
  • Serotonin syndrome: risk when combined with serotonergic agents.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

  • Renal impairment: assess renal function and consider monitoring drug levels.
  • Hepatic impairment: evaluate liver enzymes and adjust monitoring as needed.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Myelosuppression: perform regular complete blood counts.
  • Pregnancy: safety not established; weigh benefits against risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Linezolid interacts with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid)

  • MAO inhibitors: risk of hypertensive crisis.
  • Serotonergic agents (SSRIs, SNRIs, tramadol): potential serotonin syndrome.
  • Rifampin: reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect, monitor INR.
  • NSAIDs: increased bleeding risk, observe gastrointestinal tolerance.
  • Oral contraceptives: possible reduction in efficacy, advise alternative contraception.

Frequently Asked Questions

Linezolid Accord is indicated for serious Gram‑positive bacterial infections, including skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, as well as infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE).

Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex. This blocks translation, halting bacterial growth and allowing the immune system to eliminate the infection.

The dosing regimen for Linezolid Accord is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local guidelines. The prescriber sets the appropriate dose and duration.

Safety data for linezolid in pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Linezolid offers a distinct mechanism by inhibiting protein synthesis, making it effective against MRSA strains resistant to beta‑lactams and glycopeptides. Unlike some alternatives, it is available in both oral and intravenous forms, providing flexibility in step‑down therapy.

Linezolid Accord should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen. Maintain the product in its original packaging to preserve stability.

Linezolid Accord is administered intravenously by infusion, typically through a peripheral or central line. The infusion rate and duration are determined by the prescribing clinician according to the patient’s clinical condition.

Serious risks include thrombocytopenia, peripheral neuropathy, and serotonin syndrome, especially when combined with serotonergic medications. Regular monitoring of blood counts and vigilance for neurological symptoms are essential during therapy.

Patients with known hypersensitivity to linezolid or other oxazolidinones should avoid the drug. Caution is also advised for individuals taking MAO inhibitors or serotonergic agents due to the risk of severe drug interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT